SXL
STIM icon

Summit X LLC’s Neuronetics STIM Stock Holding History

Summit X LLC’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-204,202
Closed -$85K – 245
2019
Q2 		$85K Hold
204,202
– – 0.03% 226
2019
Q1 		$104K Buy
204,202
+6,807
+3% +$113K 0.04% 227
2018
Q4 		$0 Hold
197,395
– – ﹤0.01% 233
2018
Q3 		$0 Hold
197,395
– – ﹤0.01% 235
2018
Q2 		$0 Buy
+197,395
New +$5.37M ﹤0.01% 212

Other funds holding STIM

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Summit X LLC's STIM Position: Q3 2019 in Review

Summit X LLC sold out of Neuronetics (STIM) in Q3 2019, closing a stake of 204,202 shares — an estimated $85K sold.

Summit X LLC first reported a position in STIM in Q2 2018 and held it in 5 quarters. The position peaked at $104K in Q1 2019. 65 funds tracked by Wall St. Rank hold STIM as of Q3 2019.

  • Summit X LLC reported no remaining Neuronetics position as of Q3 2019 after selling out during the quarter.
  • Summit X LLC sold 204,202 Neuronetics shares in Q3 2019, an estimated $85K.
  • Summit X LLC first reported a position in Neuronetics in Q2 2018 and held it in 5 quarters.
  • Summit X LLC's Neuronetics position peaked at $104K in Q1 2019.
  • 65 funds tracked by Wall St. Rank held Neuronetics as of Q3 2019.

Based on Summit X LLC's 13F filing for Q3 2019, filed 15 Oct 2019.